A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol

The development of radiation countermeasures for acute radiation syndrome (ARS) has been underway for the past six decades, leading to the identification of multiple classes of radiation countermeasures. However, to date, only two growth factors (Neupogen and Neulasta) have been approved by the Unit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheema, Amrita K., Mehta, Khyati Y., Fatanmi, Oluseyi O., Wise, Stephen Y., Hinzman, Charles P., Wolff, Josh, Singh, Vijay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796029/
https://www.ncbi.nlm.nih.gov/pubmed/29283379
http://dx.doi.org/10.3390/ijms19010079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796029/
https://www.ncbi.nlm.nih.gov/pubmed/29283379
http://dx.doi.org/10.3390/ijms19010079

Ejemplares similares